FDA's tobacco unit pledges reset after criticism The Food and Drug Administration is pledging a reset in the agency’s tobacco program The Independent UK · Feb 24, 2023
FDA plans oversight changes after critical tobacco report - Roll Call The FDA announced a series of actions meant to improve its oversight of tobacco and nicotine products, most notably e-cigarettes. Roll Call · Feb 24, 2023
Why an ulcer drug could be the last option for many abortion patients Some abortion providers are looking to misoprostol, a medication widely used around the world, should a federal judge in Texas block access to a key medication abortion option. WEKU · Feb 24, 2023
Is reverse aging already possible? Some drugs that could treat aging might already be on the pharmacy shelves Metformin is just one of many medications being explored to slow, stop, or even reverse aging. Fortune · Feb 23, 2023
Texas judge could halt access to abortion pill mifepristone Mifepristone, legal in the US for more than 20 years, is now under threat. Al Jazeera · Feb 23, 2023
What will happen if medication abortion challenge succeeds? In the latest effort to limit abortion access, opponents of the procedure are seeking to ban one of the two drugs used in medication abortions The Independent UK · Feb 23, 2023
The FDA Will Let the Soy Boys Have Their Milk Plus: Google blocks news to Canadian users in advance of pending media law, Arizona considers zoning reform bill, and more... Reason · Feb 23, 2023
3 Bargain Stocks to Buy Before the Crowd Catches On A resilient economy and sticky inflation could lead Fed officials to hike interest rates higher than anticipated in the central bank’s next meeting. Although markets have been highly volatile amid concerns over the potential rate hikes and other macro headwinds, this has created an attractive opportunity for investors to scoop… StockNews.com · Feb 23, 2023
A bitter battle over the ‘orphan drug’ program leaves patients’ pocketbooks at risk A prescription drug that helps Lore Wilkinson walk and talk despite a rare muscle disease cost her so little for more than a decade that she didn’t even use her insurance to pay for it. But now, her Medicare insurance is shelling out about $40,000 for a one-month supply of… Tribune News Service · Feb 23, 2023
Idaho may criminalize mRNA vaccines Anti-vax Republicans lawmakers are taking a page from abortion bans — and public health experts are worried Salon · Feb 23, 2023
FDA expands contaminated eye product warning due to potential bacterial contamination, risk of blindness The Food and Drug Administration is adding to a list of eye-care products consumers should stop using “immediately” over concerns of possible bacterial contamination that could lead to blindness if infection occurs. Tribune News Service · Feb 22, 2023
No cow needed: Oat and soy can be called milk, FDA proposes Draft U.S. rules would allow soy, oat, almond and other drinks that bill themselves as “milk” to keep using the name The Independent UK · Feb 22, 2023
How abortion pills work and why they're in the spotlight Demand for abortion pills has soared since the Supreme Court decided to overturn Roe v. Wade. Axios · Feb 22, 2023
New Research Reveals Why CBD Is Such An Effective Treatment For Seizure Disorders CBD has shown remarkable efficacy in treating seizure disorders. Now we know why this might be. Inverse · Feb 22, 2023
Tribune News Service · Feb 22, 2023 What is naloxone and should everyone have access to it? Two panels that advise the Food and Drug Administration are recommending that naloxone nasal spray be approved for over-the-counter sale for emergency treatment of opioid overdoses. The Joint Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee voted unanimously to approve the measure. The FDA will…
StockNews.com · Feb 21, 2023 3 Biotech Stocks to Buy in 2023 That Could Help Set You up for Life The biotech industry is well-positioned to witness significant growth on the backs of soaring demands and government spending. Moreover, given the sector’s defensive nature, quality biotech stocks Amgen (AMGN), Gilead Sciences (GILD), and United Therapeutics Corp. (UTHR) might be solid buys in 2023 that could help you set for life.…
Chicago Tribune · Feb 21, 2023 Editorial: Abortion pill extremists are disingenuous absolutists When the U.S. Supreme Court overturned Roe v. Wade last year, freeing states to limit or ban abortion, we knew abortion pills would become a target.
The Independent UK · Feb 21, 2023 Liberia may have 'parallel system' for illegal log exports A government document obtained by The Associated Press outlines more than three dozen cases in Liberia where it appears logs were illegally cut or moved out of the country using unofficial channels
The Guardian - US · Feb 20, 2023 Starbucks vanilla drinks recalled in US over fears they may contain glass Frappuccino not sold in stores but distributed in supermarkets by PepsiCo recalled after glass detected in 13.7oz bottles
The Independent UK · Feb 20, 2023 FDA’s own reputation could be restraining its misinfo fight The U.S. Food and Drug Administration is taking aim at a new health hazard: online misinformation
StockNews.com · Feb 20, 2023 3 Stocks You Won't Have Regrets About Buying in 2023 January’s robust macroeconomic reports indicate that the Fed might raise the interest rates for longer than expected. Also, the dramatic rise in consumer debt in the fourth quarter of 2022 is a red signal for the economy. Hence, fundamentally strong stocks Pfizer (PFE), CVS Health (CVS), and Universal Logistics (ULH)…
Tribune News Service · Feb 20, 2023 What the heck is potassium sorbate? Demystifying common 'chemical sounding' food ingredients For those aspiring to eat mainly "clean ingredients," a little chemistry knowledge is often useful for deciphering packaged food labels.
WEKU · Feb 20, 2023 More than 300,000 bottles of Starbucks bottled Frappuccinos have been recalled The bottles of Starbucks' vanilla Frappuccinos may contain pieces of glass, the Food and Drug Administration said.
Salon · Feb 19, 2023 The "citizen scientist" generation rises The author of "We the Scientists" explains how a group of parents facing the worst shook up medical research
WEKU · Feb 18, 2023 Over-the-counter Narcan will save lives, experts say. But the cost will affect access Advisers to the FDA put the opioid overdose-reversal drug a step closer to being sold without a needing a prescription. Even if approved, the medication may not reach many people who need it.